Search - tctmd.com

Displaying 981 - 1000 of 1227

Sort: Relevancy | Date

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure)

Presenter: A. Pieter Kappetein, Allan Schwartz, Samir R. Kapadia

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

Presenter: A. Pieter Kappetein, Allan Schwartz, James B. Hermiller Jr.

October 30, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip)

Presenter: A. Pieter Kappetein, Allan Schwartz, Marco Barbanti

October 30, 2016

Presentation TCT 2016

TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning

Presenter: Henrique B. Ribeiro, Dimytri Alexandre Siqueira, Chris Meduri

October 30, 2016

Presentation TCT 2016

Bicuspid Aortic Valve Disease: Epidemiology, Anatomy, Classification, and Special Considerations for TAVR

Presenter: A. Pieter Kappetein, Allan Schwartz, Lars Sondergaard

October 30, 2016

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

Presentation TCT 2016

Paravalvular Leak Repair: An Emerging Structural Procedure

Presenter: Sarah Clarke, Samir R. Kapadia

October 30, 2016

Presentation TCT 2016

The Role of Non-invasive Central Aortic Pressures In Cardiovascular Disease

Presenter: Mark Reisman, Josep Rodés-Cabau, Eyal Ben -Assa

October 30, 2016

Presentation TCT 2016

PFO Closure: Rationale, Patient Selection and Outcomes

Presenter: Sarah Clarke, Megan M Kennison

October 30, 2016

Presentation TCT 2016

LAA Closure: What Have We Learned 18 Months After Approval?

Presenter: Sarah Clarke, Saibal Kar

October 30, 2016

Presentation TCT 2016

LAA Closure Review: Brief Review of Anatomy, Rationale, and Trial Results

Presenter: Sarah Clarke, Jessica Forman

October 30, 2016

Presentation TCT 2016

Germany Presents: How Did I Treat This Case

Presenter: Dariusz Dudek, Petr Kala, Michael Haude

October 30, 2016

Presentation TCT 2016

Czech Republic Responds: How Would I Treat This Case?

Presenter: Dariusz Dudek, Petr Kala, Martin Mates

October 30, 2016

Presentation TCT 2016

Germany Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Presenter: Dariusz Dudek, Petr Kala, Michael Haude

October 30, 2016

Presentation TCT 2016

Poland Presents: How Did I Treat This Case?

Presenter: Dariusz Dudek, Petr Kala, Andrzej J. Ochala

October 30, 2016

Presentation TCT 2016

France Responds: How Would I Treat This Case?

Presenter: Dariusz Dudek, Petr Kala, Patrick Ohlmann

October 30, 2016

Presentation TCT 2016

Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Presenter: Dariusz Dudek, Petr Kala, Andrzej J. Ochala

October 30, 2016

Presentation TCT 2016

Germany Presents: Treatment Options - Should Severe Mitral Regurgitation be Treated Prior, During or After TAVR (and in a Single or Staged Procedures)?

Presenter: Dariusz Dudek, Petr Kala, Holger Thiele

October 30, 2016

Presentation TCT 2016

Introduction and Session Objectives

Presenter: Dariusz Dudek, Petr Kala

October 30, 2016

Presentation TCT 2016

Czech Republic Presents: How Did I Treat This Case?

Presenter: Eric Van Belle, Jochen Wöhrle, Marian Branny

October 30, 2016

Advertisement

Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure)

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip)

TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning

Bicuspid Aortic Valve Disease: Epidemiology, Anatomy, Classification, and Special Considerations for TAVR

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Paravalvular Leak Repair: An Emerging Structural Procedure

The Role of Non-invasive Central Aortic Pressures In Cardiovascular Disease

PFO Closure: Rationale, Patient Selection and Outcomes

LAA Closure: What Have We Learned 18 Months After Approval?

LAA Closure Review: Brief Review of Anatomy, Rationale, and Trial Results

Germany Presents: How Did I Treat This Case

Czech Republic Responds: How Would I Treat This Case?

Germany Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Poland Presents: How Did I Treat This Case?

France Responds: How Would I Treat This Case?

Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Germany Presents: Treatment Options - Should Severe Mitral Regurgitation be Treated Prior, During or After TAVR (and in a Single or Staged Procedures)?

Introduction and Session Objectives

Czech Republic Presents: How Did I Treat This Case?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content